002287.SZTibet Cheezheng Tibetan Medicine Co., Ltd.
Oct 28, 2026 — Q3 2026 Earnings Announcement
Chart by TradingViewThe schedule
- Wed28Oct
Q3 2026 earnings release, providing a critical read-through on peak season sales of flagship Tibetan plasters and ointments.
- Fri20Nov
Annual National Reimbursement Drug List (NRDL) update determining standard pricing caps for the company's proprietary medicines.
- Tue30Mar
Full-year 2026 earnings release and annual dividend declaration, serving as a primary valuation anchor.
- Tue15Jun
Mid-year pipeline update on modern therapeutic crossover formulations and latest clinical trial progress.
Past
- Fri28Aug
Actual outcome: Mixed · $19.90 at outcome
Price at outcome date was between bear floor ($18.50) and bull target ($20.80).
Release of 1H 2026 interim financial results, focusing on cash flow recovery after printing a negative $163M operating cash flow last period.